Product
bezuclastinib
1 clinical trial
4 indications
Indication
Advanced Systemic MastocytosisIndication
Mast Cell LeukemiaIndication
Aggressive Systemic MastocytosisClinical trial
A Phase 2 Open-Label, Multicenter Clinical Study of the Safety, Efficacy, Pharmacokinetic, and Pharmacodynamic Profiles of CGT9486 as a Single Agent in Patients With Advanced Systemic MastocytosisStatus: Recruiting, Estimated PCD: 2025-01-01